PreviousBFM Business What's up New York: Medtech, TISSIUM lève 39 millions d'euros
NextLimFlow Announces Positive Six-month Data From PROMISE I U.S. Early Feasibility Study Demonstrating Excellent Amputation Free Survival and Wound Healing in No-option Patient Population
